CN Stock MarketDetailed Quotes

600511 China National Medicines Corporation

Watchlist
  • 31.65
  • +0.53+1.70%
Not Open Jul 17 15:00 CST
23.88BMarket Cap10.90P/E (TTM)

China National Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
7.98%12.12B
9.23%49.7B
5.75%36.53B
9.70%24.14B
1.50%11.23B
-2.09%45.5B
0.73%34.54B
-0.31%22.01B
6.93%11.06B
15.08%46.47B
Operating revenue
7.98%12.12B
9.23%49.7B
5.75%36.53B
9.70%24.14B
1.50%11.23B
-2.09%45.5B
0.73%34.54B
-0.31%22.01B
6.93%11.06B
15.08%46.47B
Other operating revenue
----
65.20%103.99M
----
680.16%41.33M
----
139.72%62.95M
----
-54.91%5.3M
----
-38.99%26.26M
Total operating cost
8.04%11.58B
9.20%47.19B
6.10%34.8B
9.79%23.01B
1.26%10.72B
-2.55%43.22B
0.36%32.8B
-0.73%20.96B
5.93%10.59B
14.34%44.35B
Operating cost
8.77%11.27B
9.67%45.7B
6.20%33.7B
9.79%22.27B
0.93%10.36B
-2.71%41.68B
0.32%31.74B
-0.70%20.29B
6.20%10.27B
15.04%42.84B
Operating tax surcharges
17.52%26.82M
2.51%114.74M
-2.53%81.01M
-12.11%46.02M
-31.11%22.82M
-6.74%111.93M
-4.32%83.12M
-0.19%52.36M
11.54%33.13M
14.32%120.02M
Operating expense
-15.37%201.45M
0.61%962.38M
0.67%681.55M
13.17%474.51M
21.42%238.03M
1.70%956.5M
1.58%677.03M
-3.15%419.28M
-7.36%196.04M
-9.13%940.48M
Administration expense
-4.45%100.53M
7.23%467.13M
7.03%307.98M
8.10%201.61M
8.86%105.22M
4.75%435.62M
6.80%287.75M
9.76%186.5M
15.44%96.65M
12.55%415.86M
Financial expense
-25.98%-28.8M
-337.33%-126.13M
12.90%-23.16M
-9.76%-22.37M
-28.57%-22.86M
-57.24%-28.84M
-100.79%-26.59M
-328.65%-20.38M
-99.21%-17.78M
-169.34%-18.34M
-Interest expense (Financial expense)
-45.09%7.32M
17.46%31.57M
86.91%35.16M
89.92%25.79M
-4.82%13.33M
-38.51%26.88M
-53.57%18.81M
-48.78%13.58M
12.63%14M
-23.06%43.71M
-Interest Income (Financial expense)
-4.91%-39.71M
-134.98%-166.37M
-24.26%-70.04M
-35.33%-54.87M
-10.56%-37.85M
-0.09%-70.8M
5.30%-56.36M
-0.05%-40.55M
-30.51%-34.24M
-20.79%-70.74M
Research and development
-16.44%13.94M
6.27%71.2M
21.24%53.17M
15.12%34.34M
24.15%16.68M
20.17%67M
11.66%43.85M
13.02%29.83M
12.30%13.44M
7.48%55.75M
Credit Impairment Loss
-224.09%-30.18M
61.49%-9.17M
-17.04%-48.62M
-103.00%-40.01M
42.23%-9.31M
27.92%-23.8M
11.74%-41.54M
34.74%-19.71M
-76.58%-16.12M
-195.87%-33.01M
Asset Impairment Loss
45.89%-2.79M
107.56%388.87K
-107.58%-21.56M
1.58%-9.44M
-76.58%-5.16M
70.77%-5.14M
53.98%-10.39M
-48.71%-9.59M
-237.17%-2.92M
-171.46%-17.59M
Other net revenue
9.76%75.66M
6.64%442.4M
16.60%266.77M
35.61%191.08M
29.23%68.93M
25.74%414.85M
18.10%228.79M
68.07%140.91M
-19.14%53.34M
1.55%329.94M
Fair value change income
----
--10.82M
--34.73M
--34.73M
----
----
----
----
----
----
Invest income
30.13%104.98M
23.09%358.95M
31.90%286.98M
48.94%197.45M
47.75%80.67M
2.92%291.62M
18.41%217.57M
37.64%132.57M
-14.42%54.6M
28.45%283.35M
-Including: Investment income associates
18.19%102.19M
19.89%456.54M
24.01%329.19M
34.29%221.04M
22.10%86.46M
0.15%380.8M
4.07%265.44M
12.63%164.59M
4.78%70.81M
16.05%380.22M
Asset deal income
97.72%-2.37K
-95.04%83.44K
-78.22%332.13K
5,435.12%460.36K
-3,795.40%-103.94K
2,460.84%1.68M
2,317.13%1.52M
45.28%-8.63K
82.15%-2.67K
-198.98%-71.25K
Other revenue
28.87%3.65M
-45.96%81.32M
-75.80%14.92M
-79.03%7.9M
-84.05%2.84M
54.72%150.49M
-22.67%61.63M
55.64%37.65M
93.90%17.78M
-20.18%97.26M
Operating profit
7.02%613.8M
9.26%2.94B
1.20%1.99B
11.05%1.32B
9.21%573.52M
10.12%2.69B
9.28%1.97B
13.44%1.19B
26.84%525.16M
27.91%2.45B
Add:Non operating Income
-28.26%629.91K
-73.18%3.01M
61.87%2.93M
236.52%1.87M
84.17%878.08K
173.35%11.21M
-38.21%1.81M
-62.13%555.09K
-10.26%476.77K
-67.72%4.1M
Less:Non operating expense
189.27%892.27K
-9.71%16.47M
-24.06%10.67M
-94.28%365.57K
-61.76%308.45K
177.78%18.24M
375.54%14.06M
3,136.25%6.39M
28,711.14%806.71K
-23.37%6.57M
Total profit
6.87%613.54M
9.04%2.93B
1.44%1.99B
11.72%1.32B
9.39%574.09M
9.94%2.69B
8.61%1.96B
12.74%1.19B
26.60%524.83M
27.51%2.44B
Less:Income tax cost
-4.26%118.42M
6.66%596.42M
-2.19%404.14M
3.50%261.83M
7.26%123.68M
8.30%559.18M
8.12%413.18M
15.58%252.98M
33.18%115.31M
26.52%516.3M
Net profit
9.93%495.12M
9.67%2.33B
2.41%1.58B
13.95%1.06B
9.98%450.41M
10.38%2.13B
8.74%1.54B
12.00%932.6M
24.86%409.53M
27.78%1.93B
Net profit from continuing operation
9.93%495.12M
9.67%2.33B
2.41%1.58B
13.95%1.06B
9.98%450.41M
10.38%2.13B
8.74%1.54B
12.00%932.6M
24.86%409.53M
27.78%1.93B
Less:Minority Profit
-0.93%35.66M
14.47%188.47M
5.77%119.61M
11.00%78.09M
0.90%36M
-5.60%164.65M
-4.96%113.09M
5.27%70.35M
18.26%35.68M
37.81%174.42M
Net profit of parent company owners
10.87%459.45M
9.26%2.15B
2.14%1.46B
14.19%984.58M
10.85%414.41M
11.97%1.96B
9.99%1.43B
12.59%862.25M
25.53%373.85M
26.86%1.75B
Earning per share
Basic earning per share
10.85%0.6089
9.27%2.8443
2.15%1.9381
14.18%1.3049
10.86%0.5493
11.97%2.6031
9.99%1.8974
12.59%1.1428
25.54%0.4955
26.86%2.3248
Diluted earning per share
10.85%0.6089
9.27%2.8443
2.15%1.9381
14.18%1.3049
10.86%0.5493
11.97%2.6031
9.99%1.8974
12.59%1.1428
25.54%0.4955
26.86%2.3248
Other composite income
-243.45%-5.85M
577.86%5.1M
140.00%1.01M
-72.16%759.79K
2,171.43%4.08M
61.53%-1.07M
54.31%-2.53M
178.86%2.73M
96.17%-196.98K
-153.05%-2.78M
Other composite income of parent company owners
-243.45%-5.85M
577.86%5.1M
140.00%1.01M
-72.16%759.79K
2,171.43%4.08M
61.53%-1.07M
54.31%-2.53M
178.86%2.73M
96.17%-196.98K
-153.05%-2.78M
Total composite income
7.65%489.27M
9.96%2.34B
2.64%1.58B
13.70%1.06B
11.03%454.49M
10.48%2.13B
8.98%1.54B
12.80%935.33M
26.79%409.33M
27.15%1.93B
Total composite income of parent company owners
8.39%453.6M
9.58%2.15B
2.39%1.46B
13.92%985.34M
12.00%418.49M
12.09%1.96B
10.26%1.43B
13.46%864.98M
27.67%373.65M
26.18%1.75B
Total composite income of minority owners
-0.93%35.66M
14.47%188.47M
5.77%119.61M
11.00%78.09M
0.90%36M
-5.60%164.65M
-4.96%113.09M
5.27%70.35M
18.26%35.68M
37.81%174.42M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 7.98%12.12B9.23%49.7B5.75%36.53B9.70%24.14B1.50%11.23B-2.09%45.5B0.73%34.54B-0.31%22.01B6.93%11.06B15.08%46.47B
Operating revenue 7.98%12.12B9.23%49.7B5.75%36.53B9.70%24.14B1.50%11.23B-2.09%45.5B0.73%34.54B-0.31%22.01B6.93%11.06B15.08%46.47B
Other operating revenue ----65.20%103.99M----680.16%41.33M----139.72%62.95M-----54.91%5.3M-----38.99%26.26M
Total operating cost 8.04%11.58B9.20%47.19B6.10%34.8B9.79%23.01B1.26%10.72B-2.55%43.22B0.36%32.8B-0.73%20.96B5.93%10.59B14.34%44.35B
Operating cost 8.77%11.27B9.67%45.7B6.20%33.7B9.79%22.27B0.93%10.36B-2.71%41.68B0.32%31.74B-0.70%20.29B6.20%10.27B15.04%42.84B
Operating tax surcharges 17.52%26.82M2.51%114.74M-2.53%81.01M-12.11%46.02M-31.11%22.82M-6.74%111.93M-4.32%83.12M-0.19%52.36M11.54%33.13M14.32%120.02M
Operating expense -15.37%201.45M0.61%962.38M0.67%681.55M13.17%474.51M21.42%238.03M1.70%956.5M1.58%677.03M-3.15%419.28M-7.36%196.04M-9.13%940.48M
Administration expense -4.45%100.53M7.23%467.13M7.03%307.98M8.10%201.61M8.86%105.22M4.75%435.62M6.80%287.75M9.76%186.5M15.44%96.65M12.55%415.86M
Financial expense -25.98%-28.8M-337.33%-126.13M12.90%-23.16M-9.76%-22.37M-28.57%-22.86M-57.24%-28.84M-100.79%-26.59M-328.65%-20.38M-99.21%-17.78M-169.34%-18.34M
-Interest expense (Financial expense) -45.09%7.32M17.46%31.57M86.91%35.16M89.92%25.79M-4.82%13.33M-38.51%26.88M-53.57%18.81M-48.78%13.58M12.63%14M-23.06%43.71M
-Interest Income (Financial expense) -4.91%-39.71M-134.98%-166.37M-24.26%-70.04M-35.33%-54.87M-10.56%-37.85M-0.09%-70.8M5.30%-56.36M-0.05%-40.55M-30.51%-34.24M-20.79%-70.74M
Research and development -16.44%13.94M6.27%71.2M21.24%53.17M15.12%34.34M24.15%16.68M20.17%67M11.66%43.85M13.02%29.83M12.30%13.44M7.48%55.75M
Credit Impairment Loss -224.09%-30.18M61.49%-9.17M-17.04%-48.62M-103.00%-40.01M42.23%-9.31M27.92%-23.8M11.74%-41.54M34.74%-19.71M-76.58%-16.12M-195.87%-33.01M
Asset Impairment Loss 45.89%-2.79M107.56%388.87K-107.58%-21.56M1.58%-9.44M-76.58%-5.16M70.77%-5.14M53.98%-10.39M-48.71%-9.59M-237.17%-2.92M-171.46%-17.59M
Other net revenue 9.76%75.66M6.64%442.4M16.60%266.77M35.61%191.08M29.23%68.93M25.74%414.85M18.10%228.79M68.07%140.91M-19.14%53.34M1.55%329.94M
Fair value change income ------10.82M--34.73M--34.73M------------------------
Invest income 30.13%104.98M23.09%358.95M31.90%286.98M48.94%197.45M47.75%80.67M2.92%291.62M18.41%217.57M37.64%132.57M-14.42%54.6M28.45%283.35M
-Including: Investment income associates 18.19%102.19M19.89%456.54M24.01%329.19M34.29%221.04M22.10%86.46M0.15%380.8M4.07%265.44M12.63%164.59M4.78%70.81M16.05%380.22M
Asset deal income 97.72%-2.37K-95.04%83.44K-78.22%332.13K5,435.12%460.36K-3,795.40%-103.94K2,460.84%1.68M2,317.13%1.52M45.28%-8.63K82.15%-2.67K-198.98%-71.25K
Other revenue 28.87%3.65M-45.96%81.32M-75.80%14.92M-79.03%7.9M-84.05%2.84M54.72%150.49M-22.67%61.63M55.64%37.65M93.90%17.78M-20.18%97.26M
Operating profit 7.02%613.8M9.26%2.94B1.20%1.99B11.05%1.32B9.21%573.52M10.12%2.69B9.28%1.97B13.44%1.19B26.84%525.16M27.91%2.45B
Add:Non operating Income -28.26%629.91K-73.18%3.01M61.87%2.93M236.52%1.87M84.17%878.08K173.35%11.21M-38.21%1.81M-62.13%555.09K-10.26%476.77K-67.72%4.1M
Less:Non operating expense 189.27%892.27K-9.71%16.47M-24.06%10.67M-94.28%365.57K-61.76%308.45K177.78%18.24M375.54%14.06M3,136.25%6.39M28,711.14%806.71K-23.37%6.57M
Total profit 6.87%613.54M9.04%2.93B1.44%1.99B11.72%1.32B9.39%574.09M9.94%2.69B8.61%1.96B12.74%1.19B26.60%524.83M27.51%2.44B
Less:Income tax cost -4.26%118.42M6.66%596.42M-2.19%404.14M3.50%261.83M7.26%123.68M8.30%559.18M8.12%413.18M15.58%252.98M33.18%115.31M26.52%516.3M
Net profit 9.93%495.12M9.67%2.33B2.41%1.58B13.95%1.06B9.98%450.41M10.38%2.13B8.74%1.54B12.00%932.6M24.86%409.53M27.78%1.93B
Net profit from continuing operation 9.93%495.12M9.67%2.33B2.41%1.58B13.95%1.06B9.98%450.41M10.38%2.13B8.74%1.54B12.00%932.6M24.86%409.53M27.78%1.93B
Less:Minority Profit -0.93%35.66M14.47%188.47M5.77%119.61M11.00%78.09M0.90%36M-5.60%164.65M-4.96%113.09M5.27%70.35M18.26%35.68M37.81%174.42M
Net profit of parent company owners 10.87%459.45M9.26%2.15B2.14%1.46B14.19%984.58M10.85%414.41M11.97%1.96B9.99%1.43B12.59%862.25M25.53%373.85M26.86%1.75B
Earning per share
Basic earning per share 10.85%0.60899.27%2.84432.15%1.938114.18%1.304910.86%0.549311.97%2.60319.99%1.897412.59%1.142825.54%0.495526.86%2.3248
Diluted earning per share 10.85%0.60899.27%2.84432.15%1.938114.18%1.304910.86%0.549311.97%2.60319.99%1.897412.59%1.142825.54%0.495526.86%2.3248
Other composite income -243.45%-5.85M577.86%5.1M140.00%1.01M-72.16%759.79K2,171.43%4.08M61.53%-1.07M54.31%-2.53M178.86%2.73M96.17%-196.98K-153.05%-2.78M
Other composite income of parent company owners -243.45%-5.85M577.86%5.1M140.00%1.01M-72.16%759.79K2,171.43%4.08M61.53%-1.07M54.31%-2.53M178.86%2.73M96.17%-196.98K-153.05%-2.78M
Total composite income 7.65%489.27M9.96%2.34B2.64%1.58B13.70%1.06B11.03%454.49M10.48%2.13B8.98%1.54B12.80%935.33M26.79%409.33M27.15%1.93B
Total composite income of parent company owners 8.39%453.6M9.58%2.15B2.39%1.46B13.92%985.34M12.00%418.49M12.09%1.96B10.26%1.43B13.46%864.98M27.67%373.65M26.18%1.75B
Total composite income of minority owners -0.93%35.66M14.47%188.47M5.77%119.61M11.00%78.09M0.90%36M-5.60%164.65M-4.96%113.09M5.27%70.35M18.26%35.68M37.81%174.42M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg